Immunophenotypic, transcriptional, and genotypic profiles in T-ALL
. | sCD3− cTCRβ− . | sCD3− cTCRβ+ . | sCD3+ TCR− . | sCD3+TCR αβ+ . | sCD3+ TCR γδ+ . | Total . | |
---|---|---|---|---|---|---|---|
IM . | Pre-αβ . | . | TCRαβ DP . | TCRαβ SP/DN . | TCRγδ . | ||
No. T-ALLs (%) | 33 (29) | 27 (24) | 9 (8) | 11 (10) | 11 (10) | 23 (20) | 114 |
Phenotype | |||||||
CD34 (%) | 22/33 (66) | 2/27 (7) | 3/9 (33) | 4/10 (40) | 4/11 (36) | 6/22 (27) | 41/112 (37) |
CD117 (%) | 2/33 (6) | 0/23 (0) | 0/5 (0) | 0/9 (0) | 0/9 (0) | 0/16 (0) | 2/93 (2) |
CD133-150 (%) | 9/33 (27) | 0/27 (0) | 0/9 (0) | 0/9 (0) | 1/9 (11) | 2/22 (9) | 12/109 (11) |
CD333-150 (%) | 12/33 (36) | 1/26 (4) | 0/9 (0) | 0/9 (0) | 1/9 (11) | 2/21 (10) | 16/107 (15) |
CD56 (%) | 9/26 (35) | 0/15 (0) | 0/6 (0) | 0/8 (0) | 0/8 (0) | 1/13 (8) | 10/76 (13) |
CD5 (%) | 25/33 (75) | 26/27 (96) | 9/9 (100) | 11/11 (100) | 11/11 (100) | 22/23 (96) | 104/113 (92) |
CD2 (%) | 16/33 (45) | 24/27 (89) | 7/9 (78) | 11/11 (100) | 9/11 (82) | 10/23 (43) | 77/114 (68) |
CD4/8 DN (%) | 25/33 (75) | 1/27 (4) | 2/9 (22) | 0/11 (0) | 3/11 (27) | 7/22 (32) | 38/113 (33) |
CD4 SP (%) | 5/33 (15) | 2/27 (7) | 1/9 (11) | 0/11 (0) | 6/11 (55) | 5/22 (23) | 19/113 (17) |
CD8 SP (%) | 2/33 (6) | 5/27 (19) | 0/9 (0) | 0/11 (0) | 2/11 (18) | 3/22 (14) | 12/113 (11) |
CD4/8 DP (%) | 1/33 (3) | 19/27 (70) | 6/9 (67) | 11/11 (100) | 0/11 (0) | 7/22 (32) | 44/113 (39) |
CD1a (%) | 6/32 (19) | 23/27 (85) | 7/9 (78) | 5/11 (45) | 5/11 (45) | 6/23 (26) | 51/113 (45) |
CD10 (%) | 8/32 (25) | 12/26 (46) | 2/9 (22) | 4/11 (36) | 2/11 (18) | 11/23 (48) | 39/112 (35) |
TdT (%) | 21/29 (72) | 20/21 (95) | 6/6 (100) | 10/11 (91) | 7/10 (70) | 10/14 (71) | 74/91 (81) |
cTCRβ (%) | 0/33 (0) | 27/27 (100) | 5/9 (56) | 7/7 (100) | 8/8 (100) | 2/15 (13) | 49/99 (50) |
PTα/RAG-13-151 | |||||||
pTα (%) | 6/31 (19) | 25/25 (100) | 7/9 (78) | 7/7 (100) | 5/9 (56) | 8/21 (38) | 58/102 (57) |
RAG-1 (%) | 6/29 (21) | 22/22 (100) | 7/9 (78) | 5/5 (100) | 6/8 (75) | 6/18 (33) | 52/91 (57) |
TCRδ PCR and/or Southern3-152 | |||||||
GL/GL cases (%) | 4/33 (12) | 0/233-153 (0) | 0/9 (0) | 0/10 (0) | 0/83-153 (0) | 0/223-153 (0) | 4/105 (5) |
R/(R-G-Del) cases (%) | 27/33 (82) | 22/27 (81) | 8/9 (89) | 4/10 (40) | 2/11 (18) | 22/23 (96) | 83/113 (75) |
Del/Del cases (%) | 2/33 (6) | 1/23 (4) | 1/9 (11) | 6/10 (60) | 6/8 (75) | 0/22 (0) | 16/105 (15) |
VD or DD alleles (%) | 18/41 (44) | 1/19 (5) | 0/12 (0) | 0/10 (0) | 0/11 (0) | 2/35 (6) | 21/114 (19) |
DJ alleles (%) | 16/41 (39) | 2/19 (11) | 1/12 (8) | 1/10 (10) | 0/11 (0) | 2/35 (6) | 21/114 (19) |
V(D)J alleles (%) | 7/41 (17) | 16/19 (84) | 11/12 (92) | 3/10 (30) | 4/11 (36) | 31/35 (89) | 66/108 (61) |
TCRγ PCR | |||||||
Neg cases (%) | 12/33 (36) | 0/27 (0) | 0/9 (0) | 0/11 (0) | 0/11 (0) | 0/23 (0) | 12/114 (11) |
Immature cases (3′V-5′J)3-155 (%) | 16/33 (49) | 15/27 (56) | 5/9 (56) | 6/11 (55) | 7/11 (64) | 15/23 (65) | 64/114 (56) |
End-stage cases (5′V-3′J)3-155 (%) | 5/33 (15) | 12/27 (44) | 4/9 (44) | 5/11 (45) | 4/11 (36) | 8/23 (35) | 38/114 (33) |
TCRβ PCR | |||||||
Neg cases (%) | 18/33 (55) | 0/26 (0) | 0/8 (0) | 0/9 (0) | 0/10 (0) | 1/19 (5) | 19/104 (18) |
Only DJ cases (%) | 7/33 (21) | 1/263-154 (4) | 2/8 (25) | 3/9 (33) | 0/10 (0) | 7/19 (37) | 20/104 (19) |
At least one V(D)J case (%) | 8/33 (24) | 25/26 (96) | 6/8 (75) | 6/9 (67) | 10/10 (100) | 11/19 (58) | 65/104 (63) |
. | sCD3− cTCRβ− . | sCD3− cTCRβ+ . | sCD3+ TCR− . | sCD3+TCR αβ+ . | sCD3+ TCR γδ+ . | Total . | |
---|---|---|---|---|---|---|---|
IM . | Pre-αβ . | . | TCRαβ DP . | TCRαβ SP/DN . | TCRγδ . | ||
No. T-ALLs (%) | 33 (29) | 27 (24) | 9 (8) | 11 (10) | 11 (10) | 23 (20) | 114 |
Phenotype | |||||||
CD34 (%) | 22/33 (66) | 2/27 (7) | 3/9 (33) | 4/10 (40) | 4/11 (36) | 6/22 (27) | 41/112 (37) |
CD117 (%) | 2/33 (6) | 0/23 (0) | 0/5 (0) | 0/9 (0) | 0/9 (0) | 0/16 (0) | 2/93 (2) |
CD133-150 (%) | 9/33 (27) | 0/27 (0) | 0/9 (0) | 0/9 (0) | 1/9 (11) | 2/22 (9) | 12/109 (11) |
CD333-150 (%) | 12/33 (36) | 1/26 (4) | 0/9 (0) | 0/9 (0) | 1/9 (11) | 2/21 (10) | 16/107 (15) |
CD56 (%) | 9/26 (35) | 0/15 (0) | 0/6 (0) | 0/8 (0) | 0/8 (0) | 1/13 (8) | 10/76 (13) |
CD5 (%) | 25/33 (75) | 26/27 (96) | 9/9 (100) | 11/11 (100) | 11/11 (100) | 22/23 (96) | 104/113 (92) |
CD2 (%) | 16/33 (45) | 24/27 (89) | 7/9 (78) | 11/11 (100) | 9/11 (82) | 10/23 (43) | 77/114 (68) |
CD4/8 DN (%) | 25/33 (75) | 1/27 (4) | 2/9 (22) | 0/11 (0) | 3/11 (27) | 7/22 (32) | 38/113 (33) |
CD4 SP (%) | 5/33 (15) | 2/27 (7) | 1/9 (11) | 0/11 (0) | 6/11 (55) | 5/22 (23) | 19/113 (17) |
CD8 SP (%) | 2/33 (6) | 5/27 (19) | 0/9 (0) | 0/11 (0) | 2/11 (18) | 3/22 (14) | 12/113 (11) |
CD4/8 DP (%) | 1/33 (3) | 19/27 (70) | 6/9 (67) | 11/11 (100) | 0/11 (0) | 7/22 (32) | 44/113 (39) |
CD1a (%) | 6/32 (19) | 23/27 (85) | 7/9 (78) | 5/11 (45) | 5/11 (45) | 6/23 (26) | 51/113 (45) |
CD10 (%) | 8/32 (25) | 12/26 (46) | 2/9 (22) | 4/11 (36) | 2/11 (18) | 11/23 (48) | 39/112 (35) |
TdT (%) | 21/29 (72) | 20/21 (95) | 6/6 (100) | 10/11 (91) | 7/10 (70) | 10/14 (71) | 74/91 (81) |
cTCRβ (%) | 0/33 (0) | 27/27 (100) | 5/9 (56) | 7/7 (100) | 8/8 (100) | 2/15 (13) | 49/99 (50) |
PTα/RAG-13-151 | |||||||
pTα (%) | 6/31 (19) | 25/25 (100) | 7/9 (78) | 7/7 (100) | 5/9 (56) | 8/21 (38) | 58/102 (57) |
RAG-1 (%) | 6/29 (21) | 22/22 (100) | 7/9 (78) | 5/5 (100) | 6/8 (75) | 6/18 (33) | 52/91 (57) |
TCRδ PCR and/or Southern3-152 | |||||||
GL/GL cases (%) | 4/33 (12) | 0/233-153 (0) | 0/9 (0) | 0/10 (0) | 0/83-153 (0) | 0/223-153 (0) | 4/105 (5) |
R/(R-G-Del) cases (%) | 27/33 (82) | 22/27 (81) | 8/9 (89) | 4/10 (40) | 2/11 (18) | 22/23 (96) | 83/113 (75) |
Del/Del cases (%) | 2/33 (6) | 1/23 (4) | 1/9 (11) | 6/10 (60) | 6/8 (75) | 0/22 (0) | 16/105 (15) |
VD or DD alleles (%) | 18/41 (44) | 1/19 (5) | 0/12 (0) | 0/10 (0) | 0/11 (0) | 2/35 (6) | 21/114 (19) |
DJ alleles (%) | 16/41 (39) | 2/19 (11) | 1/12 (8) | 1/10 (10) | 0/11 (0) | 2/35 (6) | 21/114 (19) |
V(D)J alleles (%) | 7/41 (17) | 16/19 (84) | 11/12 (92) | 3/10 (30) | 4/11 (36) | 31/35 (89) | 66/108 (61) |
TCRγ PCR | |||||||
Neg cases (%) | 12/33 (36) | 0/27 (0) | 0/9 (0) | 0/11 (0) | 0/11 (0) | 0/23 (0) | 12/114 (11) |
Immature cases (3′V-5′J)3-155 (%) | 16/33 (49) | 15/27 (56) | 5/9 (56) | 6/11 (55) | 7/11 (64) | 15/23 (65) | 64/114 (56) |
End-stage cases (5′V-3′J)3-155 (%) | 5/33 (15) | 12/27 (44) | 4/9 (44) | 5/11 (45) | 4/11 (36) | 8/23 (35) | 38/114 (33) |
TCRβ PCR | |||||||
Neg cases (%) | 18/33 (55) | 0/26 (0) | 0/8 (0) | 0/9 (0) | 0/10 (0) | 1/19 (5) | 19/104 (18) |
Only DJ cases (%) | 7/33 (21) | 1/263-154 (4) | 2/8 (25) | 3/9 (33) | 0/10 (0) | 7/19 (37) | 20/104 (19) |
At least one V(D)J case (%) | 8/33 (24) | 25/26 (96) | 6/8 (75) | 6/9 (67) | 10/10 (100) | 11/19 (58) | 65/104 (63) |
Only 5 cases (4 IM, 1 TCRαβ) expressed CD13 and CD33.
Five cases were classified as noninformative for pTα and 16 for RAG-1, including 2 IM, 6 pre-αβ, 6 TCRαβ, and 4 TCRγδ. pTα and RAG-1 expression were closely correlated, with each expressed in 57% of cases overall; 47 expressed both transcripts, and 37 expressed neither. pTα expression in the absence of RAG-1 was only seen in 2 IM, and isolated RAG-1 expression was seen in 2 IMβ and 1 DN TCRαβ. pTα and RAG-1 negativity was restricted to IM, TCRγδ, and TCRαβ SP/DN T-ALLs.
TCRδ configurations refer to T-ALL cases unless specified as (rearranged) alleles. GL indicates germline; R, rearranged; Del, deleted. TCRδ rearrangement on at least one allele was seen by Southern blot analysis in 75% of cases. In total, it was possible to identify 108 TCRδ rearrangements in 85 T-ALLs. These were classified as non–T-restricted VD ior DD, immature DJ, or complete V(D)J rearrangements.
Four pre-αβ, 3 TCRαβ, and 1 TCRγδ were TCRδ multiplex PCR negative and were not analyzed by Southern blot, thus preventing distinction between a germline, bilateral deletion, and an unidentified rearranged profile.
Because the TCRγ locus does not contain D segments, we classified T-ALLs as demonstrating an immature TCRγ recombination if a rearrangement involving Vγ9, Vγ10, Vγ11, JP, and/or JP1/2 (3′Vγ-5′Jγ) was observed on at least one allele, and as demonstrating end-stage if only Vγf1-Jγ1/2 rearrangements (5′Vγ-3′Jγ) were observed. TCRγ rearrangement on at least one allele was seen in 89% of cases. Most rearranged TCRγ alleles involved the Vγf1-Jγ1/2 (60%), Vγ10, and Vγ11 pseudogenes (22%), and Vγ9 (18%). Twenty-six JP1/2 and 2 JP (Vγf1) rearrangements were identified.
These cases probably correspond to a failure of the Vβ family-specific primers to recognize the functional rearrangement, corresponding to a 9% false-negative rate.